This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

Bayer seeks USFDA nod for Finerenone

SGLT2 inhibitors and GLP1 receptor agonists combo tied to additional heart and kidney benefits:...

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is...
View All

Latest News and Guidelines

Glipizide in T2DM Care - Latest Update from ADA 2024

Glipizide in T2DM Care - Latest Update from ADA 2024

Tamil Nadu Scales Up Type 1 Diabetes Treatment Facilities

Mediterranean and DASH diets may reduce CVD risk among adults with type 1 diabetes, reveals study

Bariatric surgery may reduce hypothalamic inflammation and modulate weight loss response: Study

Bariatric surgery may reduce hypothalamic inflammation and modulate weight loss response: Study

Could Daily Sauna Sessions Prevent Menopausal Weight Gain? Study Sheds Light

Could Daily Sauna Sessions Prevent Menopausal Weight Gain? Study Sheds Light

Artemisinins Show Promise in Treating PCOS Through LONP1-CYP11A1 Interaction: Study

Artemisinins Show Promise in Treating PCOS Through LONP1-CYP11A1 Interaction: Study

Treating obesity and fertility in the era of GLP-1 receptor agonists

GLP-1 receptor agonists show potential in reducing obesity-associated cancers among type 2 diabetes...

View All
X